News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
802,749 Results
Type
Article (60086)
Company Profile (220)
Press Release (742431)
Multimedia
Podcasts (209)
Webinars (24)
Section
Business (248513)
Career Advice (2919)
Deals (37746)
Drug Delivery (223)
Drug Development (86380)
Employer Resources (182)
FDA (17921)
Job Trends (16346)
News (369761)
Policy (36105)
Tag
2025 Best Places to Work (17)
2026 Best Places to Work (24)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (3028)
Academic (1)
Accelerated approval (75)
ADA (54)
Adcomms (43)
Allergies (230)
Alliances (52784)
ALS (288)
Alzheimer's disease (2117)
Antibody-drug conjugate (ADC) (748)
Approvals (18538)
Artificial intelligence (1005)
ASCO (343)
Autoimmune disease (522)
Automation (78)
Bankruptcy (397)
Belgium (44)
Best Places to Work (12266)
BIO (79)
Biologics (120)
BIOSECURE Act (23)
Biosimilars (302)
BioSpace Insights (189)
Biotechnology (136)
Bispecific (59)
Bladder cancer (250)
Brain cancer (100)
Breast cancer (969)
Cancer (7899)
Cardiovascular disease (669)
Career advice (2514)
Career pathing (64)
CAR-T (452)
CDC (81)
CDMO (228)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (1200)
Cervical cancer (69)
Clinical research (76699)
Collaboration (2790)
Commercialization (71)
Company closure (9)
Compensation (1930)
Complete response letters (119)
COVID-19 (3027)
CRISPR (148)
CRO (8)
C-suite (1711)
Cystic fibrosis (178)
Data (11049)
Decentralized trials (4)
Denatured (62)
Depression (225)
Dermatology (209)
Diabetes (832)
Diagnostics (7666)
Digital health (79)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (488)
Drug pricing (247)
Drug shortages (40)
Duchenne muscular dystrophy (378)
Earnings (95388)
Editorial (84)
Employer branding (24)
Employer resources (170)
ESMO (434)
Events (128991)
Executive appointments (1383)
Eye disease (26)
FDA (22981)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (29)
Frontotemporal dementia (42)
Funding (2298)
Gene editing (308)
Generative AI (93)
Gene therapy (939)
GLP-1 (1372)
Government (5286)
Grass and pollen (6)
Guidances (444)
Healthcare (20776)
Hematology (232)
HIV (125)
Huntington's disease (92)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (154)
Immunology and inflammation (403)
Immuno-oncology (158)
Indications (298)
Infectious disease (3473)
Inflammatory bowel disease (281)
Inflation Reduction Act (16)
Influenza (164)
Intellectual property (386)
Interviews (548)
IPO (17337)
IRA (59)
Job creations (4348)
Job search strategy (2049)
JPM (70)
Kidney cancer (32)
Kidney disease (177)
Labor market (129)
Layoffs (695)
Leadership (69)
Legal (8862)
Licensing (128)
Liver cancer (120)
Longevity (55)
Lung cancer (1097)
Lung diease (25)
Lymphoma (562)
Machine learning (74)
Management (68)
Manufacturing (1563)
Marketing (40)
MASH (257)
Medical affairs (5)
Medical device (15307)
Medtech (15641)
Mergers & acquisitions (21966)
Metabolic disorders (2111)
Middle East (2)
mRNA (332)
Multiple sclerosis (259)
Multispecific (7)
NASH (24)
Netherlands (38)
Neurodegenerative disease (617)
Neuropsychiatric disorders (152)
Neuroscience (4274)
Neurotech (3)
NextGen: Class of 2026 (7203)
Non-profit (4932)
Now hiring (81)
Obesity (990)
Opinion (389)
Ovarian cancer (297)
Pain (348)
Pancreatic cancer (450)
Parkinson's disease (480)
Partnered (43)
Patents (794)
Patient advocacy (7)
Patient recruitment (977)
Patient selection (116)
Peanut (80)
People (67349)
Peptides (43)
Pharmaceutical (52)
Pharmacy benefit managers (41)
Phase 1 (23813)
Phase 2 (33659)
Phase 3 (25245)
Pipeline (14546)
Policy (417)
Postmarket research (2839)
Preclinical (10221)
Press Release (72)
Prostate cancer (405)
Psychedelics (102)
Radioligand (2)
Radiopharmaceuticals (432)
Rare diseases (1561)
Real estate (6510)
Recruiting (78)
Regenerative medicine (37)
Regulatory (29506)
Reports (67)
Research institute (2726)
Resumes & cover letters (450)
Rett syndrome (60)
RNA editing (34)
RSV (103)
Saudi Arabia (1)
Schizophrenia (228)
Series A (394)
Series B (280)
Service/supplier (6)
Sickle cell disease (148)
Special edition (36)
Spinal muscular atrophy (192)
Sponsored (57)
Startups (4062)
State (2)
Stem cells (7)
Stomach cancer (23)
Substance use disorders (23)
Supply chain (163)
Switzerland (24)
Tariffs (102)
Tax incentives (2)
The Weekly (144)
Vaccines (1406)
Venture capital (173)
Weight loss (661)
Wet AMD (6)
Women's health (184)
Women in leadership (2)
Worklife (28)
Date
Today (203)
Last 7 days (906)
Last 30 days (3930)
Last 365 days (32556)
2026 (29522)
2025 (31448)
2024 (36452)
2023 (41488)
2022 (52869)
2021 (57588)
2020 (56446)
2019 (49706)
2018 (37717)
2017 (34692)
2016 (34805)
2015 (40751)
2014 (34400)
2013 (29863)
2012 (31827)
2011 (32301)
2010 (30531)
Location
Africa (982)
Alabama (117)
Alaska (7)
Arizona (467)
Arkansas (17)
Asia (45667)
Australia (7695)
California (16936)
Canada (4667)
China (2008)
Colorado (760)
Connecticut (752)
Delaware (530)
Europe (101983)
Florida (2606)
Georgia (557)
Hawaii (3)
Idaho (69)
Illinois (1433)
India (148)
Indiana (768)
Iowa (35)
Japan (775)
Kansas (157)
Kentucky (66)
Louisiana (67)
Maine (83)
Maryland (1985)
Massachusetts (12157)
Michigan (442)
Minnesota (931)
Mississippi (8)
Missouri (175)
Montana (36)
Nebraska (31)
Nevada (198)
New Hampshire (91)
New Jersey (4446)
New Mexico (35)
New York (4429)
North Carolina (2190)
North Dakota (14)
Northern California (8708)
Ohio (511)
Oklahoma (30)
Oregon (48)
Pennsylvania (3273)
Puerto Rico (38)
Rhode Island (64)
South America (1334)
South Carolina (104)
South Dakota (2)
Southern California (6827)
Tennessee (285)
Texas (2835)
United States (59921)
Utah (520)
Vermont (2)
Virginia (420)
Washington D.C. (85)
Washington State (1348)
West Virginia (4)
Wisconsin (187)
Wyoming (6)
802,749 Results for "merz aesthetics formerly known as bioform medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
November 9, 2026
·
25 min read
Press Releases
Allergan Aesthetics to Present New Research on Aesthetic Care Following Medical Weight Loss and Evolving Patient Needs at ASDS 2026
November 3, 2026
·
16 min read
Merz Aesthetics
Press Releases
Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention
October 15, 2026
·
4 min read
Press Releases
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
August 18, 2026
·
10 min read
Press Releases
Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 2026
October 26, 2026
·
5 min read
Press Releases
Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications
September 17, 2026
·
5 min read
Press Releases
Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use
November 3, 2025
·
5 min read
Press Releases
Merz Therapeutics Receives EU/EEA Approval for XEOMIN® for the Treatment of Pediatric Spasticity Associated With Pes Equinus
September 17, 2026
·
4 min read
Press Releases
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today’s Modern Aesthetics Practices
August 11, 2026
·
9 min read
1 of 80,275
Next